Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Infraglottic Capture in Anterior Glottoplasty Pitch Elevation in an Ex Vivo Porcine Model.

The Laryngoscope·2026
Same author

Beyond the City Limits: The Critical Value of Rural and Remote Medical Education Experiences.

Journal of medical education and curricular development·2026
Same author

Utility of Unified Spasmodic Dysphonia Rating Scale for Adductor Type Laryngeal Dystonia (AdLD).

The Laryngoscope·2026
Same author

Longitudinal change in swallow function in patients with Parkinson's disease (PD).

Journal of Parkinson's disease·2026
Same author

Comparing DaxibotulinumtoxinA to OnabotulinumtoxinA for Adductor Laryngeal Dystonia: A Pilot Study.

The Laryngoscope·2026
Same author

Repeat Administration and Dose Escalation of DaxibotulinumtoxinA in Adductor Type Laryngeal Dystonia.

The Laryngoscope·2026

Related Experiment Video

Updated: Jun 18, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Parathyroidectomy in the elderly population: does age really matter?

VyVy N Young1, Kyra M Osborne, Muffin M Fleming

  • 1Division of Otolaryngology, University of Louisville, Louisville, Kentucky, USA.

The Laryngoscope
|December 2, 2009
PubMed
Summary

Elderly patients undergoing parathyroidectomy experienced longer recovery times and potentially different parathyroid hormone (PTH) levels post-surgery. However, parathyroidectomy remains a safe and effective treatment for hyperparathyroidism across age groups.

Related Experiment Videos

Last Updated: Jun 18, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

  • Endocrinology
  • Surgical Outcomes
  • Geriatric Medicine

Background:

  • Parathyroidectomy is a common surgical procedure for hyperparathyroidism.
  • Patient age is a significant factor influencing surgical outcomes and recovery.
  • Understanding age-related differences in parathyroidectomy is crucial for optimizing patient care.

Purpose of the Study:

  • To compare outcomes and complications of parathyroidectomy in patients stratified by age.
  • To identify age-specific demographic differences, recovery patterns, and postoperative hormonal profiles.

Main Methods:

  • Retrospective review of a prospective parathyroidectomy database (1998-2007).
  • Analysis of 687 patients, comparing those over 65 years old with younger patients.
  • Evaluation of demographic data, length of stay, recovery room duration, and parathyroid hormone (PTH) levels.

Main Results:

  • Older patients (>65 years) had longer recovery room stays and hospital discharges.
  • Despite normocalcemia, older patients showed a trend towards persistently elevated PTH levels.
  • While overall complication rates were low and similar, elderly patients had a higher incidence of cardiac complications.

Conclusions:

  • Parathyroidectomy is safe and effective for elderly patients with hyperparathyroidism.
  • Elderly patients may experience prolonged recovery and distinct postoperative PTH patterns requiring further investigation.
  • Age-specific considerations are important for managing patients undergoing parathyroidectomy.